Source: MarketScreener

Neoleukin: NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX

(marketscreener.com) Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of Neoleukin Therapeutics, Inc. with Neurogene Inc. Under the terms of the proposed transaction, pre-merger Neoleukin stockholders are expected to own approximately 16% of the combined company and...https://www.marketscreener.com/quote/stock/NEOLEUKIN-THERAPEUTICS-I-65218886/news/NEOLEUKIN-THERAPEUTICS-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-44413444/?utm_medium=RSS&utm_content=20230725

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Donna Cochener's photo - Interim-CEO of Neoleukin

Interim-CEO

Donna Cochener

CEO Approval Rating

82/100

Read more